Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$810M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$745M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$671M |
| 4 |
Boeing
BA
|
+$390M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$361M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$784M |
| 2 |
NVIDIA
NVDA
|
+$532M |
| 3 |
Apple
AAPL
|
+$491M |
| 4 |
Amazon
AMZN
|
+$438M |
| 5 |
Newmont
NEM
|
+$399M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.71% |
| 2 | Financials | 11.26% |
| 3 | Healthcare | 8.31% |
| 4 | Industrials | 8.25% |
| 5 | Consumer Discretionary | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3901
Lucid Motors
LCID
$3.01B
| $86K | ﹤0.01% |
2,848
-3,109
| -52% | -$80.9K |
|
|
ABVX
3902
Abivax
ABVX
$10.7B
| $85.4K | ﹤0.01% |
+11,668
| New | +$107K |
|
3903
Bausch Health
BHC
$2.4B
| $84.4K | ﹤0.01% |
10,466
-194
| -2% | -$1.6K |
|
|
RVPH
3904
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $84.1K | ﹤0.01% |
+2,323
| New | +$64.7K |
|
3905
Tilray
TLRY
$573M
| $82.6K | ﹤0.01% |
6,214
-8,416
| -58% | -$123K |
|
|
DHC
3906
Diversified Healthcare Trust
DHC
$2.12B
| $82.1K | ﹤0.01% |
35,692
-156,423
| -81% | -$460K |
|
3907
BigBear.ai
BBAI
$1.33B
| $80.7K | ﹤0.01% |
+18,131
| New | +$41K |
|
|
LPRO
3908
Open Lending Corp
LPRO
| $80K | ﹤0.01% |
+13,403
| New | +$80.2K |
|
|
SAND
3909
DELISTED
Sandstorm Gold
SAND
| $79.9K | ﹤0.01% |
14,313
-1,537
| -10% | -$8.91K |
|
3910
Agilon Health
AGL
$1.56B
| $78.6K | ﹤0.01% |
+1,656
| New | +$100K |
|
3911
EVgo
EVGO
$223M
| $78.5K | ﹤0.01% |
19,386
+2,076
| +12% | +$13.2K |
|
|
SJT
3912
San Juan Basin Royalty Trust
SJT
$119M
| $78.4K | ﹤0.01% |
20,464
-500
| -2% | -$2K |
|
|
MRSN
3913
DELISTED
Mersana Therapeutics
MRSN
| $76.3K | ﹤0.01% |
2,133
+307
| +17% | +$15.9K |
|
3914
Plug Power
PLUG
$2.86B
| $75.6K | ﹤0.01% |
35,482
-8,820
| -20% | -$19.2K |
|
3915
Evolv Technologies
EVLV
$993M
| $73.5K | ﹤0.01% |
+18,618
| New | +$65.3K |
|
|
EU
3916
enCore Energy
EU
$214M
| $72.8K | ﹤0.01% |
+21,357
| New | +$80.4K |
|
|
RVNC
3917
DELISTED
Revance Therapeutics, Inc.
RVNC
| $72.1K | ﹤0.01% |
23,706
+8,326
| +54% | +$36.3K |
|
3918
Veritone
VERI
$96.7M
| $69.8K | ﹤0.01% |
21,280
| – | – |
|
3919
1stdibs.com
DIBS
$150M
| $69K | ﹤0.01% |
19,504
+737
| +4% | +$2.98K |
|
3920
ARKO Corp
ARKO
$871M
| $68.3K | ﹤0.01% |
+10,366
| New | +$71.4K |
|
3921
Vuzix
VUZI
$192M
| $68.2K | ﹤0.01% |
17,300
| – | – |
|
3922
Real Brokerage
REAX
$353M
| $64.6K | ﹤0.01% |
14,038
-206,761
| -94% | -$1.08M |
|
3923
Ardagh Metal Packaging
AMBP
$2.84B
| $63.4K | ﹤0.01% |
+21,049
| New | +$75.8K |
|
|
CMRC
3924
Commerce.com Inc Series 1
CMRC
$254M
| $63K | ﹤0.01% |
+10,289
| New | +$64.3K |
|
3925
Arbutus Biopharma
ABUS
$851M
| $61.9K | ﹤0.01% |
+18,917
| New | +$69.6K |
|
Similar funds
Ameriprise's Q4 2024 Portfolio in Review
As of Q4 2024, Ameriprise held 4,210 positions worth $390B, down 0.05% from $390B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Ameriprise's Q4 2024 filing shows 290 new, 1,777 increased, 1,865 reduced and 140 closed positions. Its largest new stake was Primo Brands: 2,607,261 shares worth $80.2M. The largest sale was Elevance Health, an estimated $784M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q4 2024 buy was Primo Brands: 2,607,261 shares worth $80.2M.
- Ameriprise added most to iShares Core US Aggregate Bond ETF in Q4 2024, an estimated $810M increase.
- Ameriprise's biggest Q4 2024 reduction was Elevance Health, cutting an estimated $784M.
- Ameriprise fully exited Primo Water Corporation in Q4 2024, selling an estimated $62.3M.
- Ameriprise's ten largest holdings make up 21% of its $390B portfolio in Q4 2024.
- Ameriprise opened 290 new positions and closed 140 in Q4 2024.
- Ameriprise's portfolio value fell 0.05% quarter-over-quarter to $390B.
Based on Ameriprise's 13F filing for Q4 2024, filed 14 Feb 2025.